Company News

Rhône To Sell Interest in Arizona Chemical

NY private equity firm to take 75% share.

Author Image

By: TOM BRANNA

Editor

Rhône Capital has entered into a definitive agreement to sell a controlling interest in Arizona Chemical to American Securities, a New York-based private equity firm. Terms of the agreement have not been disclosed.


The transaction, subject to regulatory approvals and customary closing conditions, is expected to close in the fourth quarter of this year.

Rhône, along with other currentinvestors and the management team, will retain 25% of the company’s ownershipand will continue to participate in its growth and development through pro ratarepresentation on Arizona Chemical’s board of directors, according to a press statement released today by Rhône.

“American Securities has a strong history of providing the leadership and resources necessary to ensure that the businesses that are part of their portfolio continue to achievesuccess,” explained Kees Verhaar, president and chief executive offier of Arizona Chemical. “We look forward to continuing to grow our business and strengthen our customer relationships under their leadership.”

American Securities’ portfolio includes General Chemical, MECS and Fairmount Minerals in the chemical markets.

Keep Up With Our Content. Subscribe To Happi Newsletters